Amyris Biotech Raising Series C Round
Amyris Biotechnologies Inc., an Emeryville, Calif.-based synthetic biology company that developers renewable hydrocarbon biofuels, has secured $24.75 million of a $62 million Series C round, according to a regulatory filing. The company previously raised more than $120 million, from firms like Khosla Ventures, Kleiner Perkins Caufield & Byers, DAG Ventures and TPG Biotech. www.amyrisbiotech.com
21 August 2009•1 min read
